A Comprehensive Review of Triple-Negative Breast Cancer and Recent Advances in Acridone Derivatives for Its Treatment
Triple-Negative Breast Cancer (TNBC) is an aggressive breast cancer, poorly responsive to drugs targeting hormone receptors in other breast cancer types. It is molecularly complex and aggressive, hindering therapy. Molecular characterization of TNBC has identified mutations and key signaling pathways in its develop...